Supporting Pacific eyecare
Travel restrictions have not hampered Volunteer Ophthalmic Services Overseas’ (VOSO) efforts in the Pacific, with voluntary work ongoing to support eyecare continuity.
Staff reporters2 min read
Ophthalmology News
Commonwealth commits to saving sight
The leaders of 54 Commonwealth nations have built on their 2018 agreement to a multi-pronged approach for access to screenings and affordable vision treatments, by committing to increasing access to
Staff reporters2 min read
VR-type aid for visually impaired
A US startup has developed a virtual-reality-style headset to enhance everyday activities for the visually impaired. Vision Buddy’s developers say the headset allows low vision users to view their surroundings, see faces clearly and read medicine labels – the headset can zoom in or out or read print
Staff reporters1 min read
Refraction with distraction
A UK optometrist has developed a hand-held device to maintain the attention of patients with learning disabilities or dementia during eye examinations.
Staff reporters2 min read
Hope for first DMI treatment
BI-X, the first potential treatment for diabetic macular ischaemia (DMI), a complication of diabetic retinopathy (DR), was well tolerated in a recent Phase 1/2a trial.
Staff reporters1 min read
AR contact lens – human tests begin
Mojo Vision’s augmented reality (AR) contact lens, featuring motion tracking and a pinhead-sized LED display that superimposes graphics on the wearer’s vision, has begun in-eye testing. The first to
Staff reporters1 min read
A drop for cataracts?
In an international study, led by Professor Barbara Pierscionek from Anglia Ruskin University in the UK, a new drop treatment for cataracts has shown positive results, leading to hope that an alternative to surgery could soon be possible.
Staff reporters1 min read
Myopia-preventing glasses see the light
Brooklyn-based start-up Betterlab is developing glasses to prevent myopia progression using artificial light.
Staff reporters1 min read
Faricimab – UK approval
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved faricimab (Roche, Vabysmo), the first bispecific antibody to treat neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO), for NHS patients in England.
Staff reporters2 min read
Doctors for a sustainable future
Doctors are a key part of the medical community and should lead the decarbonisation of healthcare and advocate for sustainability, according to Dr Jesse Gale, chair of the Royal Australian and New Zealand College of Ophthalmology’s (RANZCO’s) sustainability committee. Sharing this view online at RAN
Susanne Bradley4 min read
YAG laser optometry – scope change approved!
Following a successful pilot study and comprehensive consultation, the Optometrists and Dispensing Opticians Board (ODOB) has approved a new scope of practice allowing optometrists to perform ophthalmic laser surgery.
Lesley Springall4 min read
Doctors’ stress impacting care
In a recent survey, Western doctors blamed burnout and staff shortages for an increase in medical errors, while half of respondents said they had considered leaving their profession in the past three months.
Staff reporters2 min read